HD, PD, ALS iPSC Consortia Workshop

iPSC Consortia Meeting, Bethesda, Maryland, February 22nd, 2010

In 2009, through the American Recovery and Reinvestment Act (ARRA), NINDS funded three consortia, to develop well characterized, publically available, induced pluripotent stem cell (iPSC) lines for familial forms of Parkinson’s disease (PD), Huntington’s disease (HD) and Amyotrophic Lateral Sclerosis (ALS).  Because of the short two year time period for the development of these resources, NINDS organized a meeting with consortia investigators and interested non-profit organizations and industry representatives to facilitate the sharing of strategies, resources, technologies, and analyses across consortia.  

Agenda    Participant List    Executive Summary

Contact:
Margaret Sutherland, Ph.D.
National Institute of Neurological Disorders and Stroke
Phone: (301) 496-5680
E-mail: sutherlandm@ninds.nih.gov